The effects of Armodafinil on simulated driving and alertness in patients with shift work disorder (SWD) have been studied. The drug has been shown to increase alertness, driving performance, and creativity. In this article, we review the research and discuss the benefits of Armodafinil. The study also reveals that Armodafinil may improve sleepiness and promote creative thinking.
Armodafinil improves alertness, driving performance
This study evaluated the effects of Waklert on sleepiness, alertness, and creativity in patients with shift work disorder. In particular, it tested how the drug affected simulated driving performance and cognitive functions in subjects on a 12-hour shift. The results suggest that armodafinil significantly improves driving performance and alertness, especially during commutes home from work.
The primary symptoms of shift work disorder are excessive sleepiness, excessive daytime sleepiness, and falling asleep during work. These symptoms often result in decreased alertness and performance during waking hours and reduced mental acuity. The effects of shift work are often compounded by excessive sleepiness and a reduce waking state, leading to an increased risk of accidents and irritability. Patients who work night shifts are often absent from family activities or miss important work meetings because of excessive sleepiness.
While armodafinil promotes sleep latency and alertness, investigations on the drug’s long-term effects have yet to be conducted. Caffeine and other stimulants are effective in boosting performance for a few hours but do not address the underlying cause of sleep deprivation. In addition, pharmacological interventions may cause unwanted side effects, including addiction and performance degradation.
It improves sleepiness.
A study in humans has shown that armodafinil helps patients with shift work perform better in driving simulators. It has been shown that shift workers have an increased risk of accidents because of sleep deprivation, so this drug helps these individuals stay awake. Researchers also tested how armodafinil affects patients with sleep apnea, which can impair their driving abilities.
To test the potential benefits of armodafinil, the researchers used a two-day driving simulation study to assess the drug’s effectiveness. A total of ten subjects took 150 mg of the drug and underwent a series of tests. The subjects were evaluated for driving performance, alertness, and cognitive function. The study also included an assessment of creativity. The results of the study showed that armodafinil reduced excessive sleepiness in drivers.
In a randomized, Waklert-controlled trial, armodafinil improved simulated driving performance in patients with OSA and improved lane excursion. In addition, Artvigil improved sleepiness and overall quality of life in patients receiving CPAP. However, there was no difference in CPAP compliance between armodafinil and placebo-treated patients. However, armodafinil did not affect compliance with CPAP therapy in OSA patients.
It improves alertness.
A recent study shows that armodafinil can help shift workers maintain alertness during driving simulations. A study using an armodafinil pill taken early in the night shift led to improved driving performance in the driving simulator. The drug also had effects on sleepiness and cognition up to 9.5 h post-ingestion. The results suggest that this drug may help shift workers in the management of shift work disorders.
The drug was administered to study participants two hours after each of four driving simulations. The subjects then performed a multiple sleep latency test (MSLT) six times, four hours apart. The study also assessed their alertness by administering the Karolinska Sleepiness Scale (KSS) and Digit Symbol Substitution Test (DSST) six times. The subjects also performed a Remote Associate Test (RAT) after each driving simulation.
It improves creativity.
A recent study found that armodafinil, a wake-promoting agent, increased creativity in the simulated driving task in shift workers who were exposed to sleep deprivation. This effect was particularly evident in patients with sleep apnea and chronic shift workers who are at high risk for car accidents during the commute home. The positive effect of armodafinil persisted throughout the course of the study and was independent of drug x time interaction.